Jump to content

National Security Commission on Emerging Biotechnology

From Wikipedia, the free encyclopedia

The National Security Commission on Emerging Biotechnology (NSCEB) is a bipartisan U.S. legislative commission established by Congress in the 2022 National Defense Authorization Act.[1]

The NSCEB reviews how emerging biotechnology affects U.S. Department of Defense activities. It submits an interim report within one year and a final unclassified report within two years, including recommendations for Congress and the federal government.[2]

The National Security Commission on Emerging Biotechnology was announced in March 2022 and will issue a final report to Congress by 2026.[3]

Commissioners

[edit]

The NSCEB is composed of appointed commissioners:

Reports and policy recommendations

[edit]

The Commission submitted its first report to Congress in December 2023[13] which included policy recommendations related to agricultural policy for potential inclusion in the Farm Bill.[14]

In December 2023, NSCEB published its interim report, which discusses the potential applications of biotechnology in fields such as human health, food security, energy production, and economic development. The report stresses the need for the U.S. to stay ahead in biotechnology as international competition increases.[15]

In January 2024, the Commission published white papers on the integration of artificial intelligence and biotechnology ("AIxBio").[16]

In May 2024, members of Congress introduced several pieces of legislation recommended by the Commission focused on food security and agricultural security.[17]

References

[edit]
  1. ^ "Statement by the President on S. 1605, the National Defense Authorization Act for Fiscal Year 2022". 27 December 2021.
  2. ^ a b "Armed Services Committees Leadership Announces Selections for National Security Commission on Emerging Biotechnology | United States Committee on Armed Services". www.armed-services.senate.gov. Retrieved 2022-03-19.
  3. ^ https://www.biotech.senate.gov/
  4. ^ a b https://www.armed-services.senate.gov/press-releases/armed-services-committees-leadership-announces-chair-and-vice-chair-selections-for-national-security-commission-on-emerging-biotechnology
  5. ^ "Lawmakers name appointees to new emerging biotech panel | InsideDefense.com". insidedefense.com. Retrieved 2022-03-19.
  6. ^ "Young Named to National Security Commission on Emerging Biotechnology | U.S. Senator Todd Young of Indiana". www.young.senate.gov. Retrieved 2022-03-19.
  7. ^ Staff, Bio News (2024-09-27). "Exclusive: Sen. Todd Young on biosecurity, National Security Commission on Emerging Biotechnology (NSCEB)". Bio.News. Retrieved 2024-10-26.
  8. ^ "Bice Selected for National Security Commission on Emerging Biotechnology". Representative Stephanie Bice. 2022-03-17. Retrieved 2022-03-19.
  9. ^ "Indian-American Ro Khanna named to emerging biotechnology body". The American Bazaar. 2022-03-18. Retrieved 2022-03-19.
  10. ^ "The Hon. Dov S. Zakheim - Foreign Policy Research Institute". www.fpri.org. Retrieved 2022-03-19.
  11. ^ Cumbers, John. ""With Great Power Comes Great Responsibility" — Meet Alexander Titus The Department Of Defense's Head Of Biotechnology". Forbes. Retrieved 2022-03-19.
  12. ^ https://www.biotech.senate.gov/bio-dawn-meyerriecks/
  13. ^ "December 2023 New Report". Biotech. Retrieved 2024-01-19.
  14. ^ "New Biotech Commission Issues Interim Report". AIP. 2024-01-16. Retrieved 2024-02-01.
  15. ^ "NSCEB Interim Report" (PDF). National Security Commission on Emerging Biotechnology. 2023-12-01. Retrieved 2024-12-18.
  16. ^ "AIxBio White Paper 1: Introduction to AI and Biotech". Biotech. Retrieved 2024-01-27.
  17. ^ "Padilla, Young Introduce Bills on Intersection of Biotech, Agriculture, and National Security". Senator Alex Padilla. Retrieved 2024-10-26.
[edit]